Show simple item record

dc.contributor.authorMali, Kailas K.
dc.contributor.authorJ. Dias, Remeth J
dc.contributor.authorGhorpade, Vishwajeet S
dc.contributor.authorHavaldar, Vijay D
dc.date.accessioned2018-02-21T21:08:28Z
dc.date.available2018-02-21T21:08:28Z
dc.date.issued2017
dc.identifier.urihttp://hdl.handle.net/11424/6293
dc.description.abstractThe aim of present investigation was to develop a taste masked fast dissolving sublingual strips of rizatriptan benzoate. The fast dissolving strips (FDS) were prepared by solvent casting method using polyox N-10 and polyethylene glycol 400 (PEG 400) as polymer and plasticizer respectively. The FDS were evaluated for pH, folding endurance, tensile strength, moisture absorption, disintegration time and in vitro dissolution. All formulations were free from bubble and exhibited smooth appearance. The pH of the films was acidic. It was observed that increase in the concentration of polyox N-10 increased the disintegration time but reduced the dissolution rate. The formulation A2 showed all the evaluation parameters within the acceptable range and was considered as optimized formulation. The optimized formulation was subjected to the taste masking and stability study. The results of taste masking study indicated an efficient masking of the bitter taste of drug by the flavouring agents in the film. The formulation A2 was found to be stable for three months with an insignificant change in the drug content and mean dissolution time (MDT). The compatibility study performed using ATR-FTIR and DSC analysis indicated absence of any unusual interaction between drug and excipients used in formulation. Thus, the FDS comprised of polyox N-10 and PEG 400 may be a better alternative to the other available fast dissolving systems for delivery of rizatriptan benzoate.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectFast dissolving strips,Polyox N-10,PEG 400,Rizatriptan benzoateen_US
dc.titleTaste masked oral fast dissolving sublingual strips of rizatriptan benzoate for migraine therapyen_US
dc.typearticleen_US
dc.relation.journalMarmara Pharmaceutical Journalen_US
dc.identifier.volume21en_US
dc.identifier.issue2en_US
dc.identifier.startpage235en_US
dc.identifier.endpage242en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record